se of intraoperative Stimulated Raman histology for diagnosis in thoracic tumours
Recruiting
- Conditions
- C34Malignant neoplasm of bronchus and lung
- Registration Number
- DRKS00029393
- Lead Sponsor
- niversitätsklinikum FreiburgKlinik für Thoraxchirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1. Patients with suspected or proven thoracic malignancies undergoing diagnostic or curative surgeries at the Dept. for Thoracic Surgery
2. Age = 18 years
3. Informed consent prior to the procedure
Exclusion Criteria
1. Inability to understand the nature of the trial and the trial related procedures
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective is to assess the accuracy of SRH compared to conventional formalin fixed section in thoracic malignancies as following: <br>- The ability to detect infiltration of tumor<br>- The ability to characterize the origin of tumor whether from the lung or metastases <br>- The ability to identify the pathological subtypes of the tumors<br><br>The primary endpoint is the final histological diagnosis compared to the intraoperative diagnosis based on SRH.<br>
- Secondary Outcome Measures
Name Time Method Secondary endpoints include accuracy of SRH compared to FS and time taken for diagnosis on SRH vs FS.<br>